Pharmaceutical Cocrystal and Salts of Norfloxacin
Source abstract
Abstract
The aim of this study was to investigate the structural and pharmaceutical properties of norfloxacin (a poorly soluble antibacterial drug), its cocrystal, and salts. Norfloxacin in the anhydrous form (form A, 1 ) was crystallized. It was cocrystallized with isonicotinamide ( 2 ), and organic salts were prepared with succinic acid, malonic acid, and maleic acid ( 3 − 5, respectively). These phases were characterized by differential scanning calorimetry (DSC), infrared (IR) and Raman spectroscopy, and powder X-ray diffraction (PXRD). Single-crystal X-ray diffraction data were obtained, and crystal structures were solved. The apparent solubility of these phases was determined. Robust O−H···O, O−H···O -, O−H···N, N−H···O, N + −H···O -, and N−H···N interactions were present in all these structures. Quinolone moieties in these structures stack with π···π interactions and form channels to include CHCl 3 or H 2 O. Herein we report a new cocrystal and salts of norfloxacin with improved aqueous solubility.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Crystallography and molecular interactions · Crystallization and Solubility Studies · Crystal structures of chemical compounds
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Health Science, Luleå University of Technology, Luleå S-971 87, Sweden, and Energy Technology and Thermal Process Chemistry, Umeå University, Umeå S-90187, Sweden
References (36)
Show source-provided references
1. Almarsson · J. Chem. Commun. · 2004 · 188910.1039/b402150a ↗
2. Remenar J. F. · J. Am. Chem. Soc. · 2003 · 125 · 845610.1021/ja035776p ↗
3. Vishweshwar P. · J. Chem. Commun. · 2005 · 460110.1039/b501304f ↗
4. Vishweshwar P. · 2006 · 49
5. Desiraju G. R. · 1989
6. Desiraju G. R. · Angew. Chem., Int. Ed. Engl. · 1995 · 34 · 231110.1002/anie.199523111 ↗
7. Walsh R. D. B. · J. Chem. Commun. · 2003 · 18610.1039/b208574g ↗
8. Aakeröy C. B. · J. CrystEngComm · 2005 · 7 · 43910.1039/b505883j ↗
9. Childs S. L. · J. Am. Chem. Soc. · 2004 · 126 · 1333510.1021/ja048114o ↗
10. Byrn S. R. · 1999
11. Stahl P. H. · 2002
12. Reddy L. S. · Chem. Commun. · 2006 · 136910.1039/b515510j ↗
13. Bhogala B. R. · Cryst. Growth Des. · 2005 · 5 · 168310.1021/cg058012p ↗
14. Bhogala B. R. · CrystEngComm. · 2005 · 7 · 55110.1039/b509162d ↗
15. Bis J. A. · J. Cryst. Growth Des. · 2005 · 5 · 116910.1021/cg049622c ↗
16. Bhogala B. R. · Cryst. Growth Des. · 2003 · 3 · 54710.1021/cg034047i ↗
17. Aakeröy C. B. · Cryst. Growth Des. · 2003 · 3 · 15910.1021/cg025593z ↗
18. Fleischman S. G. · J. Cryst. Growth Des. · 2003 · 3 · 90910.1021/cg034035x ↗
19. Vishweshwar P. · J. Pharm. Sci.. · 2006 · 95 · 49910.1002/jps.20578 ↗
20. King A. · J. Antimicrob. Chemother. · 1986 · 18 · 110.1093/jac/18.Supplement_D.1 ↗
21. Tackás-Novák K. · J. Pharm. Sci. · 1990 · 79 · 102310.1002/jps.2600791116 ↗
22. Rose D. L. · Int. J. Pharm. · 1990 · 63 · 23710.1016/0378-5173(90)90130-V ↗
23. Ahumada A. A. · STP Pharm. Sci. · 1993 · 3 · 250
24. Tackás-Novák K. · Int. J. Pharm. · 1992 · 79 · 8910.1016/0378-5173(92)90099-N ↗
25. Barbas R. · Cryst. Growth Des. · 2006 · 6 · 146310.1021/cg060101u ↗
26. Šuštar B. · J. Therm. Anal. · 1993 · 40 · 47510.1007/BF02546616 ↗
27. Florence A. J. · Acta Crystallogr. · 2000 · 56 · 1372
28. Sheldrick G. M. · 1997
29. Higuchi T. · Adv. Anal. Chem. Instrum. · 1965 · 4 · 117
30. Hu T. C. · J. Pharm. Sci. · 2002 · 91 · 135110.1002/jps.10136 ↗
31. Neugebauer U. · Spectrochim. Acta, Part A · 2005 · 61 · 150510.1016/j.saa.2004.11.014 ↗
32. Desiraju G. R. · 1999
33. Desiraju G. R. · Chem. Commun. · 2005 · 299510.1039/b504372g ↗
34. Prasanna M. D. · J. Mol. Struct. · 2001 · 559 · 25510.1016/S0022-2860(00)00701-8 ↗
35. Wu G. · Molecules · 2003 · 8 · 28710.3390/80200287 ↗
36. Bis J. A. · J. Cryst. Growth Des. · 2005 · 5 · 116910.1021/cg049622c ↗